Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

Slides: 13–24 of 35

Clinically Significant Outcomes of Interest in the Comparative Effectiveness Review (3 of 3)

Summary of Study Characteristics Evaluated in the Comparative Effectiveness Review: PICOTS

Modes of Results Reporting and Statistical Analysis in the Comparative Effectiveness Review

Summary of Studies of Schizophrenia Included in the Comparative Effectiveness Review

Comparative Effectiveness of Haloperidol and SGAs for Treating Schizophrenia: Positive Symptoms

Comparative Effectiveness of Haloperidol and SGAs for Treating Schizophrenia: Negative Symptoms

Comparative Effectiveness of Haloperidol and SGAs for Treating Schizophrenia: General Psychopathology

Comparative Effectiveness of Haloperidol and SGAs for Treating Schizophrenia: Global Ratings/Total Scores

Comparative Effectiveness of FGAs and SGAs for Treating Schizophrenia: Other Comparisons (1 of 2)

Comparative Effectiveness of FGAs and SGAs for Treatment of Schizophrenia: Other Comparisons (2 of 2)

Comparative Effectiveness of FGAs and SGAs for Treating Schizophrenia: Response and Remission Rates

Pages: Previous 1 [2] 3 Next